We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 36

Dechert survey of securities fraud class actions brought against U.S. life sciences companies

  • Dechert LLP
  • -
  • USA
  • -
  • March 16 2015

The past year was particularly noteworthy with respect to the relative number of securities fraud class action lawsuits brought against publicly

Pleading still matters: Shareholders failed to properly plead scienter

  • Bricker & Eckler LLP
  • -
  • USA
  • -
  • April 1 2014

Despite the complexities involved in securities fraud actions, the Sixth Circuit recently reminded litigants that adequately pleading facts to

2013 year-end Foreign Corrupt Practices Act update

  • Baker & Hostetler LLP
  • -
  • Libya, USA
  • -
  • February 10 2014

The third and fourth quarters of 2013 proved to be eventful and poten- tially prophetic as to the course the Foreign Corrupt Practices Act ("FCPA"

U.S. Supreme Court Matrixx decision rejects statistical significance as bright-line test of materiality

  • Hogan Lovells
  • -
  • USA
  • -
  • April 11 2011

In its unanimous opinion in Matrixx Initiatives, Inc. v. Siracusano issued on March 22, the U.S. Supreme Court reaffirmed its long-established standard for determining materiality with respect to securities fraud claims under Section 10(b) of the Securities Exchange Act of 1934 and the SEC's Rule 10b-5

State AGs in the news

  • Dickstein Shapiro LLP
  • -
  • USA
  • -
  • May 15 2014

Bernard Nash and Milton A. Marquis Hot News Blog Post: Think You're Not a Holder of Unclaimed Property? Think Again! All 50 states have unclaimed

Supreme Court holds that issuers can be liable for omitting material facts from statements of opinion in Omnicare case

  • Mintz Levin Cohn Ferris Glovsky and Popeo PC
  • -
  • USA
  • -
  • March 25 2015

In its opinion in Omnicare, Inc. v. Laborers District Council Construction Industry Pension Fund, released yesterday, the U.S. Supreme Court held

Third Circuit vacates dismissal of Celebrex securities fraud class action

  • Locke Lord LLP
  • -
  • USA
  • -
  • February 17 2009

The United States Court of Appeals for the Third Circuit (“Third Circuit”) recently vacated the dismissal of a securities fraud class action alleging that a pharmaceutical company, Pharmacia, Inc., made materially false statements about a clinical study of a popular anti-inflammatory medication

Denial of leave to amend securities complaint affirmed on basis of futility

  • Katten Muchin Rosenman LLP
  • -
  • USA
  • -
  • March 28 2008

The Court of Appeals for the Eighth Circuit affirmed a decision dismissing Plaintiff’s class action securities fraud complaint and denying Plaintiff leave to amend

Insider trading developments - Summer 2014

  • Schulte Roth & Zabel LLP
  • -
  • USA
  • -
  • July 31 2014

The U.S. Securities and Exchange Commission and Department of Justice are continuing to investigate and prosecute insider trading cases at a rate not

Scienter inadequately pled under the standard set forth in the PSLRA

  • Katten Muchin Rosenman LLP
  • -
  • USA
  • -
  • October 8 2010

The U.S. District Court for the Southern District of Indiana dismissed plaintiff’s securities fraud action against a nationwide health care benefits provider, and its officers and directors, in which plaintiff alleged that defendants artificially inflated the price of the stock by making certain false and misleading statements